Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for acute isolated optic neuritis
ACTRN12611000350921Phase 3Active, not recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in optic neuritis (ON) comparing Memantine with Placebo (2 arms). Primary endpoints: Visual acuity and Retinal nerve fiber layer thickness. Started Apr 2010; status: active, not recruiting.
02
Drugs
memantine
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on ACTRN12611000350921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000350921.